Skip to main content
All lobbying filings

LIVANOVA USA, INC.

LIVANOVA USA, INC. filed a Q3 report for LIVANOVA USA, INC. on October 20, 2026.

Lobbying for LIVANOVA USA, INC.

All filings by LIVANOVA USA, INC. · Everything LIVANOVA USA, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Expenses
$200,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Texas

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Issues related to Medicare beneficiary access to treatments for depression and epilepsy.

Issues related to epilepsy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem